Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · IEX Real-Time Price · USD
2.120
-0.020 (-0.93%)
At close: Jul 19, 2024, 4:00 PM
2.160
+0.040 (1.89%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $159.00 million as of July 22, 2024. Its market cap has increased by 565.26% in one year.
Market Cap
159.00M
Enterprise Value
148.91M
1-Year Change
565.26%
Ranking
Category
Stock Price
$2.12
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $159.00M, an increase of 211.59%. That is a compound annual growth rate of 51.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 159.00M | 783.33% |
| Dec 29, 2023 | 18.00M | 73.08% |
| Dec 30, 2022 | 10.40M | -75.53% |
| Dec 31, 2021 | 42.50M | -16.71% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TriSalus Life Sciences | 162.45M |
| FibroBiologics | 160.74M |
| INmune Bio | 159.84M |
| scPharmaceuticals | 159.36M |
| Achieve Life Sciences | 159.00M |
| Assertio Holdings | 156.00M |
| Rani Therapeutics Holdings | 155.29M |
| OptiNose | 153.53M |